Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The small hydrophobic (SH) glycoprotein ectodomain is the extracellular portion of the SH protein, a minor surface protein of respiratory syncytial virus (RSV). It modulates host immune responses, inhibits TNF-α signaling, and may be involved in apoptosis regulation. The ectodomain sequence, NKLCEYNVFHNKTFELPRARVNT (for RSV-A), is highly conserved and used in vaccine development to elicit specific antibody responses.
Antibody binding to ectodomain; inhibition of viral entry or immune modulation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small Hydrophobic Glycoprotein Ectodomain of Respiratory Syncytial Virus (SH ectodomain).